Table 3.
MMP3 SNP genotypes and the risk of ankylosing spondylitis
| SNP | Genotype | Control, n(%) | Case, n(%) | p |
|---|---|---|---|---|
| rs639752 | ||||
| A/A | 287 (44%) | 117 (43.7%) | 0.707 | |
| A/C | 309 (47.3%) | 123 (45.9%) | ||
| C/C | 57 (8.7%) | 28 (10.4%) | ||
| rs520540 | ||||
| G/G | 287 (44%) | 117 (43.7%) | 0.707 | |
| A/G | 309 (47.3%) | 123 (45.9%) | ||
| A/A | 57 (8.7%) | 28 (10.4%) | ||
| rs646910 | ||||
| T/T | 534 (81.7%) | 224 (83.6%) | 0.516 | |
| A/T | 113 (17.3%) | 43 (16%) | ||
| A/A | 7 (1.1%) | 1 (0.4%) | ||
| rs679620 | ||||
| C/C | 286 (43.9%) | 112 (42%) | 0.832 | |
| C/T | 306 (46.9%) | 128 (47.9%) | ||
| T/T | 60 (9.2%) | 27 (10.1%) | ||
| rs522616 | ||||
| T/T | 270 (41.3%) | 95 (35.7%) | 0.008 | |
| C/T | 282 (43.1%) | 143 (53.8%) | ||
| C/C | 102 (15.6%) | 28 (10.5%) | ||
Abbreviation: CI, Confidence interval; OR, Odds ratio; SNPs, Single nucleotide polymorphisms.
p < 0.05 indicates statistical significance.